COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 462: Articles 4611-4620  | Next

Covid-19 Vaccination in India: An Exploratory Analysis
Agarwal, S. K., Naha, M.
10.1101/2023.02.01.23285134 — Posted: 2023-02-02
Household Hardships during the COVID-19 Pandemic: Examining Household Vulnerability and Responses to Pandemic Related Shocks in Eastern Ethiopia
Muir, J. A., Deresa, M., Madewell, Z. J., Getachew, T., Mangesha, G., Whitney, C. G., Assefa, N., Cunningham, S. A.
10.1101/2023.02.01.23285322 — Posted: 2023-02-02
Determinants of COVID-19 vaccine uptake in the Netherlands: an ecological analysis
Labuschagne, L. J. E., Smorenburg, N., van de Kassteele, J., Bom, B., de Weerdt, A., de Melker, H. E., Hahne, S.
10.1101/2023.02.01.23284949 — Posted: 2023-02-02
Immunogenicity of the BA.1 and BA.4/5 Bivalent Boosts: A Brief Report of Preliminary Results from the COVAIL Randomized Clinical Trial
Branche, A. R., Rouphael, N., Losada, C., Baden, L. R., Anderson, E. J., Luetkemeyer, A. F., Diemert, D. J., Winokur, P. L., Presti, R. M., Kottkamp, A. C., Falsey, A. R., Frey, S. E., Rupp, R., Backer, M., Novak, R. M., Walter, E. B., Jackson, L. A., Little, S. J., Immergluck, L. C., Mahgoub, S. M., Whitaker, J. A., Babu, T. M., Goepfert, P. A., Fusco, D. N., Atmar, R. L., Posavad, C. M., Netzl, A., Smith, D. J., Telu, K., Mu, J., Matkowski, M., Makhene, M., Crandon, S., Montefiori, D. C., Roberts, P. C., Beigel, J. H.
10.1101/2023.01.31.23285306 — Posted: 2023-02-02
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: randomised, active-controlled, observer-blinded, phase 3 trial
Song, J. Y., Choi, W. S., Kim, E. J., Heo, J. Y., Lee, J. S., Jung, D. S., Kim, S.-W., Park, K.-H., Eom, J. S., Jeong, S. J., Lee, J., Kwon, K. T., Choi, H. J., Sohn, J. W., Kim, Y. K., Yoo, B. W., Jang, I.-J., Wysocki, P., Roman, F., Breuer, T., Kim, H., Ryu, J. H., Park, Y. W., Lee, S. J., Sahastrabuddhe, S., Song, M., D'Cor, N., Carter, L., Capeding, M. R., Philippot, A., Solmi, F., Ceregido, M., Park, H., Lee, Y. Y., Thaisrivichai, P., D'Souza, S., Seo, S. H., Shim, B.-S., Carlos, J., Alberto, E., Nitayaphan, S., Ratanasuwan, W., Mootsikapun, P., Chaiwarit, R., Quang, L. C., Karpenko, O., Yurkiv, T., Kutovyi, V., Bartko, A., Gyrina, O., Barna, O., Pugach, M., Thurlow, C., Carson, S., Smith, S., Williams, M., Hemi, T., Humphrey, T., Sheahan, D., Kang, S. G., Cheong, H. j.
10.1101/2023.01.31.23284895 — Posted: 2023-02-02
Food Insecurity amid COVID-19 Lockdowns: Assessing Sociodemographic Indicators of Vulnerability in Harar and Kersa, Ethiopia
Muir, J. A., Deresa, M., Madewell, Z. J., Getachew, T., Mengesha, G., Whitney, C. G., Assefa, N., Cunningham, S. A.
10.1101/2023.01.31.23284545 — Posted: 2023-02-02
Associations between reported healthcare disruption due to COVID-19 and avoidable hospitalisation: Evidence from seven linked longitudinal studies for England
Green, M. A., McKee, M., Hamilton, O., Shaw, R., MacLeod, J., Boyd, A., The LH&W NCS Collaborative, , Katikireddi, S. V.
10.1101/2023.02.01.23285333 — Posted: 2023-02-02
Clinical Characteristics and Long-term Symptomology of Post-COVID-19 Olfactory and Gustatory Dysfunction
Boyd, A., Minichetti, D. G., Lemire, E. R., Haber, A. L., Roditi, R. E., Laidlaw, T. M., Bankova, L. G.
10.1101/2023.02.01.23285224 — Posted: 2023-02-02
Development of a mobile laboratory system in hydrogen fuel cell buses and evaluation of the performance for COVID-19
Okude, M., Suzuki, K., Naito, A., Ebashi, A., Kusama, T., Kiyotaki, J., Akashi, Y., Kiyasu, Y., Kurihara, Y., Notake, S., Takansahi, M., Setoyama, T., Kawakami, Y., Suzuki, H.
10.1101/2023.01.30.23285220 — Posted: 2023-02-02
Global generalisability of AI-driven COVID-19 vaccination policies: a cross-sectional observational study
Awasthi, R., Nagori, A., Nasri, B.
10.1101/2023.01.31.23285300 — Posted: 2023-02-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).